On June 3, 2022, The Kensington Private Equity Fund announced its acquisition of Resolute Health Corporation Limited, a leading Canadian healthcare services business specializing in the testing and treatment of obstructive sleep apnea. Resolute, founded in 2005 in Dartmouth and headquartered in Bedford, Nova Scotia, has grown to become the largest independent provider of sleep therapy in Eastern Canada and a national leader in obstructive sleep apnea diagnosis and treatment. At the time of the transaction, Resolute operated 72 clinics under nine regional brands across six provinces and had provided testing and therapy to more than 250,000 patients. Kensington, an employee-owned alternative investment firm founded in 1996 with $2.5 billion in assets under management, pursued the acquisition to support further scaling of Resolute’s operations across Canada. In connection with the transaction, Kensington’s Managing Director, Kirk Hamilton, joined Resolute’s board alongside Kensington Principal, Jordan Bruce. Torkin Manes LLP acted for Resolute Health Corporation and Bennett Jones acted for Kensington.